3 Indian Stocks Trading Far Below Fair Value on Strong Cash Flows
Central banks are shifting gears on interest rates and bond buybacks, which is putting fresh attention on cash flows and balance sheet strength. When policy signals feel uncertain, stocks that produce solid cash and still trade below estimated fair value can look especially appealing. This article highlights three stocks from the Undervalued Stocks Based On Cash Flows screener that may offer that mix of resilience and mispricing.
The three stocks that follow are just a starting sample from this idea, with the full screen surfacing 25 more companies with similarly cash rich profiles and valuation gaps that are not covered here. To see the wider opportunity set, head straight to the Undervalued Stocks Based On Cash Flows screener to identify, filter and analyze the highest conviction plays for your watchlist.
Entero Healthcare Solutions (NSEI:ENTERO)
Overview: Entero Healthcare Solutions is a Mumbai based distributor that connects pharmaceutical companies and medical device makers with pharmacies, hospitals and clinics across India, using central warehousing and last mile delivery to generate recurring cash flows from essential healthcare products and its Entero Surgicals private label line.
Operations: Entero generates all of its ₹71,278.88 million revenue from trading pharmaceutical and surgical products in India.
Market Cap: ₹60.36 billion
Entero Healthcare Solutions may be worth a closer look for investors seeking exposure to recurring healthcare distribution cash flows backed by scale. According to Simply Wall St, the stock currently trades about 49.6% below their DCF estimate of fair value. Earnings grew 22.3% last year and are forecast, by Simply Wall St, to grow 34.23% a year, supported by higher margin medical devices and private label products. Recent results show revenue of ₹19,435.02 million and net income of ₹381.62 million in Q1 FY2026, indicating that cash generation is already meaningful. The trade off is thin 1.8% net margins, full reliance on external borrowing and a relatively new management team. For investors comfortable with those risks, the combination of cash flow potential and discounted valuation may be appealing.
Entero Healthcare Solutions’ cash rich distribution model and discounted share price are pulling in attention, but the real twist may sit in the detailed DCF valuation analysis for Entero Healthcare Solutions and what it hints at for those thin margins and future cash generation.
Build your own cash flow shortlist around Entero Healthcare Solutions
Entero Healthcare Solutions and the other two stocks in this article all surfaced from a single screener, but your edge comes from tailoring the filters to your own style. Use our flexible Screener to combine valuation, growth, balance sheet and risk metrics, or jump straight into our curated Investing Ideas for ready made shortlists.
S H Kelkar (NSEI:SHK)
Overview: S H Kelkar is a Mumbai based fragrance and flavor group that creates scents for personal, home and fabric care products and food flavors in liquid, emulsion and dry forms. It sells these recurring, formulation based ingredients to FMCG customers and exporters, which is the main cash flow engine that ties it to the Undervalued Stocks Based On Cash Flows screener.
Operations: S H Kelkar generates most of its revenue from fragrances at about ₹36,051.4 million, with a smaller ₹3,411.6 million contribution from flavors and a segment adjustment of ₹15,057.3 million.
Market Cap: ₹22.15 billion
Investors looking for cash flow stories backed by everyday consumer demand may find S H Kelkar interesting. The core fragrances and flavors business feeds into FMCG supply chains, and Simply Wall St’s DCF suggests the stock trades about 48% below estimated fair value, which lines up neatly with the Undervalued Stocks Based On Cash Flows theme. Recent Q1 FY2027 results showed revenue above ₹6,500 million and net income of ₹454 million, with profit margins under pressure from raw material costs and expansion spending. Together with efforts to improve inventory efficiency and reduce net debt, this points to a business where the cash flow profile is changing, but funding risks, low interest coverage and an unstable dividend record mean investors may want to look more closely before committing capital.
S H Kelkar’s cash engine from everyday consumer demand could be masking a much sharper valuation reset. Review the 2 key rewards and 4 important warning signs (1 is major!) to see how those fragrance cash flows compare with the hidden pressure points
Mangalore Refinery and Petrochemicals (BSE:500109)
Overview: Mangalore Refinery and Petrochemicals is an India based refiner that processes crude oil into fuels like diesel, petrol, LPG and naphtha, along with petrochemicals such as polypropylene, supplying both domestic and export markets. These large scale refining and petrochemical operations are the main reason it appears in the Undervalued Stocks Based On Cash Flows screener, because they generate recurring operating cash flows that feed into discounted cash flow valuation work.
Operations: Mangalore Refinery and Petrochemicals generates all of its ₹1,095,649.5 million revenue from the downstream petroleum sector.
Market Cap: ₹309.33 billion
Some investors interested in cash rich industrial companies may keep Mangalore Refinery and Petrochemicals on the radar. Its refinery and polypropylene businesses have reported Q1 FY2027 revenue of ₹416,798.5 million and net income of ₹9,456.8 million, and Simply Wall St’s DCF suggests the stock trades 47.8% below estimated fair value. At the same time, the company still relies on imported crude, carries debt that is not well covered by operating cash flow and faces long term questions around fuel demand and energy transition. Together with ongoing retail expansion, governance changes and new project leadership, this is a business where the cash flow profile is still evolving and may warrant a closer look from some investors.
Mangalore Refinery and Petrochemicals looks like a classic valuation story, with sizeable cash flows meeting a discounted price. The full analysis report for Mangalore Refinery and Petrochemicals could clarify whether that gap reflects a temporary refiner cycle or something far more structural.
Seeking Fresh Alternatives Before Others Do
Fresh ideas with breakout potential rarely stay under the radar for long. Screen for momentum while it matters, before prices start flying or dropping, and get in early.
- Track early leaders in gold as momentum builds, then size up opportunities using the curated 30 elite gold producer stocks before the crowd catches on.
- Hunt for under the radar compounders by scanning the 611 high quality undiscovered gems so you spot quality stories before sentiment and prices run away.
- Pinpoint steady compounders with strong balance sheets using the curated list of solid balance sheet and fundamentals (433 results) and consider whether you may be exposed to fragile stocks when conditions turn.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com